Translate this page into:
Atypical Truncal Localisation of Cutaneous Larva Migrans: Expanding the Clinical Spectrum
*Corresponding author: Ravi Kumar, Department of Dermatology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. rverma12310@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Kumar R, Kathuria S. Atypical Truncal Localisation of Cutaneous Larva Migrans: Expanding the Clinical Spectrum. Indian J Postgrad Dermatol. doi: 10.25259/IJPGD_11_2026
A 42-year-old female presented with multiple twisting, pruritic, thread-like eruptions over the abdomen and back for 2.5 months. Lesions began on the anterior abdomen and spread posteriorly in a serpiginous pattern, migrating about 10 cm/week. She had close contact with a household dog. Examination showed an erythematous, non-tender serpiginous tract from the anterior to the posterior trunk as shown in figure 1a and 1b. Laboratory tests revealed eosinophilia (450 cells/µL) with normal other findings. Histopathology showed perivascular lymphohistiocytic infiltrate with eosinophils. Treatment with albendazole 400 mg daily for 3 days and a single oral dose of ivermectin 12 mg led to complete resolution within 7 days.
Ethical approval:
The Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given consent for their images and other clinical information to be reported in the journal. The patient understands that the patient’s names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship: Nil.